Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicityCAVALETTI, G; ZANNA, C.European journal of cancer (1990). 2002, Vol 38, Num 14, pp 1832-1837, issn 0959-8049Article

Good Clinical Practice and study monitoring : results of an Italian survey of the clinical monitorDE TOMASI, F; ZANNA, C.International journal of pharmaceutical medicine. 2000, Vol 14, Num 1, pp 23-25, issn 1364-9027Article

Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertensionMALATINO, L. S; STANCANELLI, B; GRECO, G et al.Cardiovascular drugs and therapy. 1990, Vol 4, pp 123-126, issn 0920-3206, SUP1Conference Paper

The antihypertensive effect of ketanserin versus captopril determined by harmonic fittingGERMANO, G; DAMIANI, S; PECCHIOLI, V et al.Current therapeutic research. 1991, Vol 49, Num 1, pp 65-73, issn 0011-393X, 9 p.Article

Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumorsSESSA, C; CRESTA, S; ZANIBONI, A et al.Annals of oncology. 2007, Vol 18, Num 3, pp 561-568, issn 0923-7534, 8 p.Article

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy ScaleCAVALETTI, G; BOGLIUN, G; ZANNA, C et al.Neurology. 2003, Vol 61, Num 9, pp 1297-1300, issn 0028-3878, 4 p.Article

Ketanserin alone and in combination with enalapril in the treatment of essential hypertension : assessment of the haemodynamic effectsDE DIVITIIS, O; GALDERISI, M; CELENTANO, A et al.Journal of international medical research. 1993, Vol 21, Num 3, pp 113-125, issn 0300-0605Article

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapyCAVALETTI, G; BOGLIUN, G; FEI, F et al.Annals of oncology. 2004, Vol 15, Num 9, pp 1439-1442, issn 0923-7534, 4 p.Article

Rare mtDNA variants in Leber hereditary optic neuropathy families with recurrence of myoclonusLA MORGIA, C; ACHILLI, A; VETRUGNO, R et al.Neurology. 2008, Vol 70, Num 10, pp 762-770, issn 0028-3878, 9 p.Article

Antihypertensive and metabolic effects of ketanserin in patients with hypertension and impaired glucose tolerance : a double-blind randomized, placebo-controlled, crossover studyDESSI-FULGHERI, P; ZANNA, C; DI NOTO, G et al.Current therapeutic research. 1991, Vol 49, Num 2, pp 249-255, issn 0011-393X, 7 p.Article

Ketanserin and captopril interaction in the treatment of essential hypertensivesLAVEZZARO, G; LADETTO, P. E; VALENTE, M et al.Cardiovascular drugs and therapy. 1990, Vol 4, pp 119-122, issn 0920-3206, SUP1Conference Paper

Safer by design: towards a conceptual assessment of safetyDE ZANNA, C; VAN TOOREN, M; SCHUT, J et al.Transactions on the built environment. 2009, Vol v. 108, pp 105-116, issn 1746-4498, isbn 978-1-8456-4193-1 1-8456-4193-0, 1Vol, 12 p.Conference Paper